The novel therapy of this peptide represents a significant breakthrough in the management of diabetes mellitus type 2. Unlike existing drugs, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and the https://tirzepatidepeptide000920.worldblogged.com/48413075/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment